Search alternatives:
largest decrease » marked decrease (Expand Search)
longer decrease » linear decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
Showing 1,261 - 1,280 results of 1,326 for search 'significantly ((((longer decrease) OR (largest decrease))) OR (larger decrease))', query time: 0.24s Refine Results
  1. 1261

    Figure 2. by Guolian Wu (21464168)

    Published 2025
    “…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
  2. 1262

    KEGG Enrichment Analysis. by Guolian Wu (21464168)

    Published 2025
    “…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
  3. 1263

    Figure 1. by Guolian Wu (21464168)

    Published 2025
    “…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
  4. 1264

    Gene Name to ID Conversion. by Guolian Wu (21464168)

    Published 2025
    “…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
  5. 1265

    Bar Chart. by Guolian Wu (21464168)

    Published 2025
    “…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
  6. 1266

    Filter Samples with p < 0.05. by Guolian Wu (21464168)

    Published 2025
    “…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
  7. 1267

    KEGG Diagram. by Guolian Wu (21464168)

    Published 2025
    “…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
  8. 1268

    Grouping and Sorting. by Guolian Wu (21464168)

    Published 2025
    “…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
  9. 1269

    Violin Plot. by Guolian Wu (21464168)

    Published 2025
    “…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
  10. 1270

    XCell Algorithm for Immune Cell Matrix. by Guolian Wu (21464168)

    Published 2025
    “…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”
  11. 1271

    Image 1_Sepsis in Internal Medicine: blood culture-based subtypes, hospital outcomes, and predictive biomarkers.tiff by Gaetano Zizzo (15853004)

    Published 2025
    “…Median length of stay (LOS) was 14 days, and mean ward-to-intensive care unit (ICU) transfer and in-hospital mortality rates were 11 and 26%, respectively; significant differences were observed over the years, with LOS peaks preceding mortality peaks by 1 year. …”
  12. 1272

    Data Sheet 1_The effect of mepolizumab dosage form on treatment outcomes in severe asthma.pdf by Martina Vetchá (21143222)

    Published 2025
    “…</p>Results<p>Three months after initiation of administration, all methods showed improvement compared to the values at the beginning of treatment, with ER decreasing from a median of 4 to 0. Similarly, the median OCS decreased from 5 mg to 0 mg across all methods throughout the treatment. …”
  13. 1273

    Image 2_Sepsis in Internal Medicine: blood culture-based subtypes, hospital outcomes, and predictive biomarkers.tiff by Gaetano Zizzo (15853004)

    Published 2025
    “…Median length of stay (LOS) was 14 days, and mean ward-to-intensive care unit (ICU) transfer and in-hospital mortality rates were 11 and 26%, respectively; significant differences were observed over the years, with LOS peaks preceding mortality peaks by 1 year. …”
  14. 1274

    Data Sheet 1_GBD: incidence rates and prevalence of anxiety disorders, depression and schizophrenia in countries with different SDI levels, 1990–2021.pdf by Jueqi Wang (21376073)

    Published 2025
    “…</p>Results<p>In countries with different SDI levels, the age-standardized average annual percentage change (AAPC) in the incidence of anxiety were all shown to be increasing, and there were large gender differences between the different SDI levels, with a maximum of 0.97 (0.76–1.18) for females in countries with a high SDI level, Age-standardized more rates per 100,000 people in high SDI countries, from 658.87 in 1990 to 841.56 in 2021, and the largest gender differences in countries with a low to moderate SDI level, with AAPCs for males and females of 0.04 (0.04–0.05), 0.86 (0.63–1.09); for depression, only the countries with medium-high SDI levels were statistically significant compared to the countries with medium-low SDI levels, with AAPCs of 0.05 (0.04–0.07), 0.04 (0.04–0.05); for schizophrenia in addition to the AAPCs of the countries with medium-high SDI levels showed an increase of 0.16 (0.13–0.18); the rest decreased.…”
  15. 1275

    Data Sheet 1_Instructors as communication strategists: using multimodal communication to implement a new course policy on assignment extension due dates.docx by Joseph M. Ruesch (18194605)

    Published 2025
    “…Increasing the number of communication channels decreased the confusion about the extension policies. …”
  16. 1276
  17. 1277
  18. 1278

    Image 2_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.jpeg by Ömer Bektaş (13827139)

    Published 2025
    “…CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …”
  19. 1279

    Table 1_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx by Ömer Bektaş (13827139)

    Published 2025
    “…CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …”
  20. 1280

    Image 1_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.jpeg by Ömer Bektaş (13827139)

    Published 2025
    “…CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …”